Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

COVID-19 doesn't make alopecia areata worse.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

Alopecia areata patients have a higher risk of other immune-related diseases.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

CAR is a useful marker for assessing alopecia areata severity.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

People with alopecia areata have lower blood zinc and iron, and higher hair iron, copper, chromium, and nickel.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Vitamin D may help prevent or reduce hair loss after COVID-19.

Vitamin D receptor is crucial for hair health and may help treat hair loss.

Radiation-induced hair loss may be caused by hair growth stopping and inflammation in blood vessels.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Integrative hair therapy improved hair loss and regrowth.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Tinea capitis can occur in adults and should be considered if scalp issues persist.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.